Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
Jerry T. Wu(National Institutes of Health), Javed Khan(National Cancer Institute)
Cited by 12
Related Papers
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models
|Journal of Clinical Investigation|2009|322
Clonality and Evolutionary History of Rhabdomyosarcoma
|PLoS Genetics|2015|76